Form 4: Labcorp EVP Exercises RSUs, Sells Shares for Tax

Labcorp's EVP, CIO & CTO, Akinbolade Oyegunwa, exercised restricted stock units and sold a portion of the resulting shares to cover tax obligations.

Summary

• Akinbolade Oyegunwa, EVP, CIO & CTO of Labcorp Holdings Inc., exercised 230 Restricted Stock Units (RSUs) on February 11, 2026.
• Each RSU represents the contingent right to receive one share of Labcorp Common Stock.
• Following the RSU exercise, Oyegunwa directly owned 4,174.253 shares of Common Stock.
• Concurrently, 68 shares of Common Stock were disposed of at a price of $289.89 per share to satisfy tax withholding obligations.
• After these transactions, Oyegunwa directly holds 4,106.253 shares of Common Stock and 2,190 Restricted Stock Units.
• The vested RSUs were part of a grant that vests in three equal annual installments, with the first installment vesting on February 11, 2026.
• The transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), indicating a pre-scheduled event.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a routine executive compensation transaction where the executive continues to hold significant equity, aligning interests with shareholders.

Positives

• The executive is exercising RSUs, indicating continued participation in the company's equity program.
• The executive retains a significant number of shares (4,106.253) and additional RSUs (2,190) after the transactions, demonstrating ongoing alignment with shareholder interests.

Negatives

• A portion of shares (68 shares) was sold, though this was for tax withholding purposes, which is a common and expected practice.

Future Outlook

The filing indicates future vesting events for the remaining 2,190 Restricted Stock Units, as they are part of a grant that vests in three equal annual installments starting February 11, 2026.

Industry Context

StockSavvy.ai notes that executive RSU exercises and subsequent tax-related sales are routine events in public companies, reflecting standard executive compensation practices and tax planning. This particular transaction for Labcorp's EVP is consistent with typical insider activity for vested equity awards, especially when executed under a Rule 10b5-1 plan.

Comparison to Industry Standards

• Executive equity compensation, including Restricted Stock Units (RSUs) and their vesting schedules, is a standard practice across industries, particularly in large healthcare and diagnostic companies like Quest Diagnostics or IDEXX Laboratories.
• The practice of selling a portion of vested shares to cover tax obligations (known as "sell-to-cover") is also a common and accepted method for executives to manage their tax liabilities upon equity award vesting, aligning with practices seen at comparable firms.
• The use of a Rule 10b5-1 plan for these transactions is a standard corporate governance practice to mitigate concerns about insider trading, ensuring transactions are pre-scheduled and not based on material non-public information.

Stakeholder Impact

• Shareholders: The executive's continued significant equity holding aligns their interests with shareholders. The sale for tax purposes is a minor, routine event and does not indicate a lack of confidence.
• Employees: No direct impact mentioned.

Next Steps

• Future annual installments of the RSU grant will vest on subsequent February 11th dates.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the exercise of Restricted Stock Units and a sell-to-cover for tax obligations, executed under a Rule 10b5-1 plan. It does not provide new fundamental information about Labcorp's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The executive retains a substantial equity stake, which is a positive sign of alignment, but the transaction itself is not a catalyst for significant price movement. Therefore, a "hold" recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider filing.

Keywords

Labcorp Holdings Inc., LH, Akinbolade Oyegunwa, Insider Trading, Form 4, Restricted Stock Units, RSU Exercise, Stock Sale, Executive Compensation, Tax Withholding, Rule 10b5-1